The Agency intends to enter into a Contract with one or more Respondents for the provision of
Blood Glucose Test Strips as set forth in the Rebate Agreement and in accordance with
the following specifications:
A. Rebate offers must be expressed as a Guaranteed Net Unit Price (GNUP) for each
National Drug Code (NDC) the Respondent wishes to be considered.
B. The GNUP will be calculated as the State Maximum Allowable Cost (SMAC)
for blood glucose test strips as determined by the OMPP in effect on the last day
of the calendar quarter that corresponds to the calendar quarter for which the State
utilization is reported to the Respondent, adjusted to reflect a per-unit rate (i.e.,
per test strip) currently $0.7344 per unit minus the per-unit rebate for each
submitted NDC.
C. The Respondent must agree to supply test strip monitors at no charge to the Agency, members, Physicians and or Prescribers and Providers. Respondent
must ensure that providers will be able to purchase Blood Glucose Test
Strips for members for a price below the SMAC rate.
D. The Respondent must agree to waive any processing and/or dispensing fee to
FSSA for distribution of Blood Glucose Test Strips and/or Blood Glucose Test
Strip Monitors.
E. The Respondent shall submit to the State the proposed strategy to be used in order
to ensure a comprehensive transition of IHCP members to a new blood glucose
monitor. Please highlight a specific work plan for monitor distribution at no cost
to the members and providers. At a minimum, this strategy must include
providing a dedicated twenty-four (24) hour seven (7) days a week toll-free phone
number and website for its customer service for blood glucose test strip monitor
training. This strategy shall also include placement of staff members to educate
and assist members in the initiation of the program, as well as to provide
continued member education. Respondents shall assist in drafting communication
to providers and members regarding changes associated with the rebate program
and shall be responsible for all postage and handling costs. The Respondent shall
provide information regarding the Respondents proven market share of blood
glucose test strip products within the current IHCP population.